Abbott (NYSE:ABT) announced that it launched the Jot Dx — its latest insertable cardiac monitor (ICM) — in the U.S. Jot Dx offers clinicians and hospitals control of the management of the flow of information through a feature that allows the viewing of abnormal heart rhythm data. It can simplify which irregular heart rhythms are […]
Heart Rhythm Society
Medtronic (NYSE:MDT) announced today that the FDA cleared two of its AccuRhythm AI algorithms for use with the Linq II ICM. Fridley, Minn.–based Medtronic’s AccuRhythm AI applies artificial intelligence to heart rhythm event data collected by the Linq II insertable cardiac monitor (ICM) to improve the information provided to physicians for better diagnoses and treatments […]
A Philadelphia cardiologist has written a newspaper column questioning the efficacy and cost of Boston Scientific’s Watchman device for stroke prevention. The Watchman left atrial appendage closure device is designed to prevent blood clots that form in the heart’s left atrial appendage from reaching the brain. Boston Scientific (NYSE:BSX) markets it as an alternative to blood-thinning […]
Airport body scanners don’t appear to interfere with pacemakers and defibrillators, and noninvasive neurostimulation through the ear may help treat AFib. Those are but some of the insights coming out of the Heart Rhythm Society’s annual scientific sessions, held this week in San Francisco. Here are some of the research highlights coming out of the […]
The Heart Rhythm Society this week released its guidelines on device lead management and extraction for implantable cardiovascular electronic devices. The new guidelines are the result of a collaboration amongst 10 international organizations, according to the HRS. Included contributing organizations are the HRS, American College of Cardiology, American Heart Association, Asia Pacific Heart Rhythm Society, […]
A bevy of cardiac medical societies updated their guidelines for stroke treatment yesterday to take into account new devices and technology, including left atrial appendage occlusion devices, stent retrievers and thrombectomy devices. The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions have updated their guidelines to include the benefits of left […]
A new study in the journal Heart Rhythm shows the utility of Zoll Medical‘s LifeVest wearable defibrillator for a subset of patients who don’t start out with the device.
Updated May 12, 2014, at 5:30 p.m. with confirmation from St. Jude Medical.